First Oral Antiviral for COVID-19, Lagevrio (Molnupiravir), Approved By MHRA
The Medicines and Healthcare products Regulatory Agency (MHRA) announced. Today that the antiviral Lagevrio (molnupiravir) is safe and effective. At reducing the risk of hospitalization and death in people with mild to moderate COVID-19. Who